Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Role of Biologics in Psoriasis
Biologics have revolutionized the treatment of psoriasis, offering targeted therapies that specifically address the underlying mechanisms of the disease. Unlike traditional systemic treatments, which can have broad immunosuppressive effects, biologics target specific components of the immune system involved in psoriasis pathogenesis. This precision has led to significant improvements in efficacy and safety for patients with moderate to severe psoriasis. The most commonly used biologics in psoriasis treatment include TNF inhibitors, IL-12/23 inhibitors, IL-17 inhibitors, and IL-23 inhibitors. These biologics have demonstrated remarkable success in reducing psoriatic lesions, improving skin clearance, and enhancing the quality of life for patients. Clinical trials and real-world studies have shown that biologics can achieve rapid and sustained remission in many patients, with some experiencing near-complete resolution of their symptoms.
Therefore, get an overall knowledge of updated Role of Biologics in Psoriasis
See More Webinars @ Hidoc Webinars
1.
Newly identified T-cell subtype may explain treatment-resistant childhood leukemia
2.
Glioblastoma treatment breakthrough shows promise
3.
A computer-aided diagnostic system for improved detection of breast cancer.
4.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
5.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
1.
Liquid Biopsies in Hematology: A Window into the Disease
2.
Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology
3.
A Visual Guide to Understanding Breast Cancer Staging
4.
Exploring the Latest Treatments for Essential Thrombocythemia
5.
Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
3.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
Navigating the Complexities of Ph Negative ALL - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation